On December 17, 2015, the Federal Circuit declined to review a decision which tossed $30 million in supplemental damages that was awarded to Dow Chemical Co. from a dispute with Finnegan client NOVA Chemicals Corp.
In 2010, a district court found that NOVA infringed Dow's patent. As a result of the case, Dow was awarded $30 million in supplemental damages for NOVA's sales during 2010 and 2011. However, soon after Dow was awarded supplemental damages, the Supreme Court handed down its decision in Nautilus. NOVA appealed the supplemental damages decision and the Federal Circuit held that the difference in the indefiniteness standard before and after Nautilus was so significant that while Dow's patents were valid under the old standard, they are invalid under the new one. The Federal Circuit therefore threw out the $30 million award. Dow urged for a rehearing, but the Federal Circuit declined.
United States Court of Appeals for the Federal Circuit (CAFC), Nautilus Inc. v. Biosig Instrument Inc., NOVA Chemicals Corp., damages
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Press Release
Finnegan and BMW Group Successfully Demolish Non-Practicing Entity NorthStar’s Efforts
April 3, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.